Genetics in the management of adult de novo AML.
Bloomfield
Clara D
CD
The Ohio State University Comprehensive Cancer Center, USA.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use; D002869:Chromosome Aberrations; D002871:Chromosome Banding; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007621:Karyotyping; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics* / Q000601:surgery; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011379:Prognosis; D011446:Prospective Studies; D014178:Translocation, Genetic; D014182:Transplantation, Autologous; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine